Advertisement
Research Article| Volume 17, ISSUE 3, P465-481, September 1997

Autoimmune Reactivity in Inflammatory Bowel Disease

  • David F. Keren
    Correspondence
    Address reprint requests to David F. Keren, MD, Warde Medical Laboratory, 5025 Ventura Drive, Ann Arbor, MI 48108
    Affiliations
    From the Warde Medical Laboratory (DFK), Department of Pathology, St. Joseph Mercy Hospital

    The Department of Pathology (DFK), University of Michigan, Medical School, Ann Arbor, Michigan
    Search for articles by this author
  • James A. Goeken
    Affiliations
    The Immunopathology Laboratory (JAG), University of Iowa Hospitals and Clinics

    The Department of Pathology (JAG), University of Iowa College of Medicine, Iowa City, Iowa
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30206-3
Autoimmune Reactivity in Inflammatory Bowel Disease
Previous ArticleSerodiagnosis of Celiac Disease
Next ArticleAutoimmune Liver Diseases
      This paper is only available as a PDF. To read, Please Download here.
      Inflammatory bowel disease remains a poorly understood chronic inflammatory condition of the bowel. No etiologic agents, or agreed upon pathogenesis is currently known. Recent findings that perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) are present in the vast majority of patients with this disease have proven to be of use in epidemiologic studies. Its clinical use is currently being explored by several investigators.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Aitola P.
        • Miettinen A.
        • Mattila A.
        • et al.
        Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis.
        J Clin Pathol. 1995; 48: 645-647
        • Allan A.
        • Wyke J.
        • Allan R.N.
        • et al.
        Plasma fibronectin in Crohn's disease.
        Gut. 1989; 30: 627-633
        • Anton P.A.
        • Targon S.R.
        • Shanahan F.
        Increased neutrophil receptors for and response to the proinflammatory bactererial peptide formyl-methionyl-leucyl-phenvlalanine in Crohn's disease.
        Gastroenterology. 1989; 97: 20-28
        • Becken W.L.
        Transmissible agents in inflammatory bowel disease.
        Med Clin North Am. 1980; 64: 1021-1035
        • Billing P.
        • Tahir S.
        • Calfin B.
        • et al.
        Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies.
        Am J Pathol. 1995; 147: 979-987
        • Bosch X.
        • Asherson R.A.
        The antigenic significance and methods of detection of the anti-neutrophil cytoplasmic autoantibodies (ANCA).
        Postgrad Med J. 1992; 68: 707-713
        • Broberger O.
        • Perlmann P.
        Autoantibodies in human ulcerative colitis.
        J Exp Med. 1959; 110: 657-674
        • Broekroelofs J.
        • Mulder A.H.L.
        • Nelis G.F.
        • et al.
        Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD): Relation to disease pattern and disease activity.
        Dig Dis Sei. 1994; 39: 545-549
        • Brynskov J.
        • Freund L.
        • Rasmussen S.N.
        • et al.
        A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.
        N Engl J Med. 1989; 321: 845-850
        • Cambridge G.
        • Rampton D.S.
        • Stevens T.R.J.
        Antineutrophil antibodies in inflammatory bowel disease: Prevalence and diagnostic role.
        Gut. 1992; 33: 668-674
        • Chadwick V.S.
        Enzyme in neutrophiles by intestinal bacteria in vitro and in vivo.
        Scand J Gastroenterol. 1988; 23: 121-128
        • Chester J.F.
        • Ross J.S.
        • Malt R.A.
        • Weitzman S.A.
        Acute colitis produced by chemotactic peptides in rats and mice.
        Am J Pathol. 1985; 125: 284-290
        • Davies D.J.
        • Moran J.E.
        • Niall J.F.
        • Ryan G.B.
        Segmental necrotizing glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology?.
        BMJ. 1982; 285: 606
        • Delpre G.
        • Kadish U.
        • Gazet E.
        • et al.
        HLA antigens in ulcerative colitis and Crohn's disease in Israel.
        Gastroenterology. 1980; 78: 1452-1457
        • Edgar J.D.M.
        The clinical utility of ANCA positivity.
        Ann Rheum Dis. 1996; 55: 494-496
        • Elson C.O.
        • James S.P.
        • Graeff A.S.
        • et al.
        Hypogammaglobulinemia due to abnormal suppressor T-cell activity in Crohn's disease.
        Gastroenterology. 1984; 86: 569-576
        • Elson C.O.
        • Graeff A.S.
        • James S.P.
        • Strober W.
        Covert suppressor T cells in Crohn's disease.
        Gastroenterology. 1981; 80: 1513-1521
        • Fiocchi C.
        • Youngman K.R.
        • Farmer R.G.
        Immunoregulatory function of human intestinal mucosa lymphoid cells: Evidence for enhanced suppressor cell activity in inflammatory bowel disease.
        Gut. 1983; 23: 692-701
        • Fiocchi C.
        • Roche J.K.
        • Michener W.M.
        High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives.
        Ann Intern Med. 1989; 110: 786-794
        • Fuss I.J.
        • Neurath M.
        • Boirivant M.
        • et al.
        Disparate CD4 + lamina propria (LP) lympho- kine secretion profiles in inflammatory bowel disease.
        Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996; 157: 1261-1270
        • Ginsburg C.H.
        • Falchuk Z.M.
        Defective autologous mixed-lymphocyte reaction and suppressor cell generation in patients with inflammatory bowel disease.
        Gastroenterology. 1982; 83: 1-9
        • Gould S.R.
        • Brash A.R.
        • Conolly M.E.
        Increased prostaglandin production in ulcerative colitis.
        Lancet. 1977; 2: 98-99
        • Gross W.L.
        • Schmitt W.H.
        • Csemok E.
        ANCA and associated diseases: Immunodiagnos- tic and pathogenetic aspects.
        Clin Exp Immunol. 1993; 91: 1-12
        • Haagsma E.B.
        • Mulder A.H.L.
        • Gouw A.S.H.
        • et al.
        Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
        J Hepatol. 1993; 19: 8-14
        • Haistensen T.S.
        • Mollnes T.E.
        • Fausa O.
        • Brandtzaeg P.
        Deposis of terminal complement components in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon.
        Gut. 1989; 30: 361-366
        • Hardarson S.
        • LaBrecque D.R.
        • Mitros F.A.
        • et al.
        Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases.
        Am J Clin Pathol. 1993; 99: 277-281
        • Hawkey C.J.
        • Truelove S.C.
        Effect of prednisolone on prostaglandin synthesis by rectal radioimmunoassay.
        Gut. 1981; 22: 190-193
        • Heatley R.V.
        • Calcraft B.J.
        • Rhodes J.
        • et al.
        Disodium cromoglycate in the treatment of chronic proctitis.
        Gut. 1975; 16: 559-563
        • Hertervig E.
        • Wieslander J.
        • Johansson C.
        • et al.
        Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease.
        Prevalence and diagnostic role. Scand J Gastroenterol. 1995; 30: 693-698
        • Hodgson H.J.F.
        • Potter B.J.
        • Jewell D.P.
        Immune complexes in ulcerative colitis and Crohn's disease.
        Clin Exp Immunol. 1977; 29: 187-196
        • Hodgson H.J.F.
        • Potter B.J.
        • Skinner J.
        • Jewell D.P.
        Immune complex-mediated colitis in rabbits.
        An experimental model. Gut. 1978; 19: 225-232
        • Hodgson H.J.F.
        • Potter F.J.
        • Jewell D.P.
        C3 metabolism in ulcerative colitis and Crohn's disease.
        Clin Exp Immunol. 1977; 29: 490-495
        • Holdstock G.
        • Chastenay B.F.
        • Krawitt E.L.
        Increased suppressor cell activity in inflammatory bowel disease.
        Gut. 1981; 22: 1025-1030
        • James S.A.
        Remission of Crohn's disease after human immunodeficiency virus infection.
        Gastroenterology. 1988; 95: 1687-1689
        • Jennette J.C.
        • Falk R.J.
        Antineutrophil cytoplasmic auto-antibodies and associated diseases: A review.
        Am J Kidney Dis. 1990; 15: 517-529
        • Jennette J.C.
        • Falk R.J.
        Antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
        Am J Clin Pathol. 1993; 99: 221-223
        • Jewell D.P.
        • MacLennan I.C.M.
        Circulating immune complexes in inflammatory bowel disease.
        Clin Exp Immunol. 1977; 14: 219-226
        • Johnson R.J.
        The mystery of the antineutrophil cytoplasmic antibodies.
        Am J Kidney Dis. 1995; 26: 57-61
        • Kagnoff M.F.
        • Brown F.J.
        • Schanfield M.S.
        Association between Crohn's disease and immunoglobulin heavy chain (Gm) allotypes.
        Gastroenterology. 1983; 85: 1044-1047
        • Kallenberg C.G.M.
        • Mulder A.H.L.
        • Tervaert J.W.C.
        Antineutrophil cytoplasmic antibodies: A still-growing class of autoantibodies in inflammatory disorders.
        Am J Med. 1992; 93: 675-682
        • Kelleher D.
        • Murphy A.
        • Whelan C.A.
        • et al.
        Defective suppression in the autologous mixed lymphocyte reaction in patients with Crohn's disease.
        Gut. 1989; 30: 839-844
        • Kemler B.J.
        • Alpert E.
        Inflammatory bowel disease associated circulating immune complexes.
        Gut. 1980; 21: 195-201
        • Keren D.F.
        • Kumar N.B.
        • Appelman H.D.
        Quantification of IgA-containing plasma cells as an adjunct to histopathology in distinguishing acute self-limited colitis from active idiopathic inflammatory bowel disease.
        Pathology and Immunopathology Research. 1987; 6: 435-441
        • Kett K.
        • Rognum T.O.
        • Brandtzaeg P.
        Mucosal subclass distribution of immunoglobulin-producing cells is different in ulcerative colitis and Crohn's disease of the colon.
        Gastroenterology. 1987; 93: 919-924
        • Kett K.
        • Brandtzaeg P.
        • Fausa O.
        J-chain expression is more prominent in immunoglobulin A2 than in immunoglobulin Al colonic immunocytes and is decreased in both subclasses associated with inflammatory bowel disease.
        Gastroenterology. 1988; 94: 1419-1425
        • Kim W.H.
        • Choi P.M.
        • Landers C.J.
        • Targan S.R.
        Role of antineutrophil cytoplasmic antibodies in an ethnically distinct population: Korean patients with ulcerative colitis.
        Am J Gastroenterol. 1995; 90: 1-6
        • Kozarek R.A.
        • Patterson D.J.
        • Gilfand M.D.
        • et al.
        Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease.
        Ann Intern Med. 1989; 110: 353-356
        • Lake A.J.
        • Stitzel A.E.
        • Urmson J.R.
        • et al.
        Complement alterations in inflammatory bowel disease.
        Gastroenterology. 1979; 76: 1374-1379
        • Lauritsen K.
        • Laursen L.S.
        • Bukhave K.
        • Rask-Masden J.
        Effects of topical 5-aminosali- cylic acid and prednisolone on prostaglandin E2 leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis.
        Gastroenterology. 1986; 91: 837-844
        • Lee S.S.
        • Lawton J.W.M.
        • Chak W.
        Distinction between antinuclear antibody and P- ANCA.
        J Clin Pathol. 1991; 44: 962-963
        • Levine T.S.
        • Tzardi M.
        • Mitchell S.
        • et al.
        Diagnostic difficulty arising from rectal recovery in ulcerative colitis.
        J Clin Pathol. 1996; 49: 319-323
        • Lloyd G.
        • Green F.H.Y.
        • Fox H.
        • et al.
        Mast cells and immunoglobulin E in inflammatory bowel disease.
        Gut. 1975; 16: 861-866
        • MacDermott R.P.
        • Nash G.S.
        • Auer I.O.
        • et al.
        Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease.
        Gastroenterology. 1989; 96: 764-768
        • Maeoni G.
        • Bollani S.
        • Bianchi Porro G.
        Ultrasonographic detection of intestinal complications in Crohn's disease.
        Dig Dis Sei. 1996; 41: 1643-1648
        • Mahida Y.R.
        • Wu K.
        • Jewell D.P.
        Enhanced production of interleukin 1-B by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease.
        Gut. 1989; 30: 835-838
        • Markey B.A.
        • Warren J.S.
        Use of anti-neutrophil cytoplasmic antibody assay to distinguish between vasculitic disease activity and complications of cytotoxic therapy.
        Am J Clin Pathol. 1994; 102: 589-594
        • Mayer L.
        • Shlien R.
        Evidence for function of la molecules on gut epithelial cells in man.
        J Exp Med. 1987; 166: 1471-1483
        • Mee A.S.
        • McLaughlin J.E.
        • Hodgson H.J.F.
        • Jewell D.P.
        Chronic immune colitis in rabbits.
        Gut. 1979; 20: 1-8
        • Modigliani R.
        Prostanoids in ulcerative colitis.
        Gastroenterology. 1982; 82: 819
        • Mulder A.H.L.
        • Broekroelofs J.
        • Horst G.
        • et al.
        Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: Characterization and clinical correlates.
        Clin Exp Immunol. 1994; 95: 490-497
        • Mulder A.H.L.
        • Heeringa P.
        • Brouwer E.
        • et al.
        Activation of granulocytes by antineutrophil cytoplasmic antibodies (ANCA): A FcgammaRII-dependent process.
        Clin Exp Immunol. 1994; 98: 270-278
        • Mulder A.H.L.
        • Stegeman C.A.
        • Kallenberg C.G.M.
        Activation of granulocytes by antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: A predominant role for the IgG3 subclass of ANCA.
        Clin Exp Immunol. 1995; 101: 227-232
        • Niles J.L.
        Antineutrophil cytoplasmic antibodies in the classification of vasculitis.
        Annu Rev Med. 1996; 47: 303-313
        • O'Donoghue D.P.
        • Kumar P.
        Rectal IgE cells in inflammatory bowel disease.
        Gut. 1979; 20: 149-153
        • Otto H.F.
        Immunpathogenetische and ultrastrukturelle Aspekte der Colitis ulcerosa.
        Schweiz Med Wochenschr. 1981; 111: 768-773
        • Papo M.
        • Quer J.C.
        • Pastor R.M.
        • et al.
        Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease.
        Am J Gastroenterol. 1996; 91: 1512-1515
        • Pool M.O.
        • Ellerbroek P.M.
        • Ridwan B.U.
        • et al.
        Serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease are mainly associated with ulcerative colitis.
        A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical and surgical treatment. Gut. 1993; 34: 46-50
        • Potter B.J.
        • Hodgson H.J.F.
        • Mee A.S.
        • Jewell D.P.
        Clq metabolism in ulcerative colitis and Crohn's disease.
        Gut. 1979; 20: 1012-1019
        • Potter B.J.
        • Brown D.J.C.
        • Watson A.
        • Jewell D.P.
        Complement inhibitors and immunocon- glutinins in ulcerative colitis and Crohn's disease.
        Gut. 1980; 21: 1030-1034
        • Rachmilewitz D.
        • Ligumsky M.
        • Haimovitz A.
        • Treves A.J.
        Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel.
        Gastroenterology. 1982; 82: 673-679
        • Rampton D.S.
        • Sladen G.E.
        Prostaglandin synthesis inhibitors in ulcerative colitis: Flurbiprofen compared with conventional treatment.
        Prostaglandins. 1981; 21: 417-425
        • Rampton D.S.
        • Sladen G.E.
        • Youlten L.J.F.
        Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.
        Gut. 1980; 21: 591-596
        • Reumaux D.
        • Colombel F.
        • Delecourt L.
        • et al.
        Antineutrophil cytoplasmic auto-antibodies (ANCA) in patients with ulcerative colitis (UC): Influence of disease activity and familial study.
        in: Gross W.L. ANCA-Associated Vasculitides: Immunological and Clinical Aspects. Plenum Press, New York1993: 515-518
        • Rhodes J.M.
        • McLaughlin J.E.
        • Brown D.J.C.
        • et al.
        Inhibition of leucocyte motility and prevention of immune-complex experimental colitis by hydroxychloroquine.
        Gut. 1982; 23: 181-187
        • Roche J.K.
        • Fiocchi C.
        • Youngman K.
        Sensitization to epithelial antigens in chronic mucosal inflammatory disease: Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro.
        J Clin Invest. 1985; 75: 522-530
        • Rosekrans P.C.M.
        • Meyer C.J.L.M.
        • Vander Wal A.M.
        • Lindeman J.
        Allergic proctitis, a clinical and immunopathological entity.
        Gut. 1980; 21: 1017-1023
        • Rosekrans P.C.M.
        • Meijer C.J.
        • Van der Val A.M.
        • et al.
        Immunoglobulin containing cells in inflammatory bowel disease of the colon: A morphometric and immunohistochemical study.
        Gut. 1980; 21: 941-947
        • Rump J.A.
        • Scholmerich J.
        • Gross V.
        • et al.
        A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.
        Immunobiology. 1990; 181: 406-413
        • Sandborn W.J.
        • Landers C.J.
        • Tremaine W.J.
        • Targan S.R.
        Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: Results of a pilot study.
        Mayo Clin Proc. 1996; 71: 431-436
        • Sandborn W.J.
        • Landers C.J.
        • Tremaine W.J.
        • Targan S.R.
        Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis.
        Am J Gastroenterol. 1995; 90: 740-747
        • Satsangi J.
        • Grootscholten C.
        • Holt H.
        • Jewell D.P.
        Clinical patterns of familial inflammatory bowel disease.
        Gut. 1996; 38: 738-741
        • Schnabel A.
        • Hauschild S.
        • Gross W.
        Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases.
        Int Arch Allergy Immunol. 1996; 109: 201-206
        • Schumacher G.
        • Kollberg B.
        • Sandstedt B.
        • et al.
        Circulating granulocyte antibodies in first attacks of colitis.
        Scand J Gastroenterol. 1995; 30: 157-163
        • Scott M.G.
        • Nahm H.
        • Macke K.
        • et al.
        Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: Differences between ulcerative colitis, Crohn's disease, and controls.
        Clin Exp Immunol. 1986; 66: 209-215
        • Seibold F.
        • Slametschka D.
        • Gregor M.
        • Weber P.
        Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis.
        Gastroenterology. 1994; 107: 532-536
        • Seibold F.
        • Weber P.
        • Klein R.
        • et al.
        Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
        Gut. 1992; 33: 657-662
        • Selby W.S.
        • Jewell D.P.
        The T lymphocyte subsets in inflammatory bowel disease: Peripheral blood.
        Gut. 1983; 24: 99-105
        • Selby W.S.
        • Janossy G.
        • Mason D.W.
        • Jewell D.P.
        Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.
        Clin Exp Immunol. 1983; 53: 614-618
        • Seldenrijk C.A.
        • Drexhage H.L.A.
        • Meuwissen S.G.M.
        • et al.
        Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease.
        Gut. 1989; 30: 484-491
        • Shanahan F.
        • Duerr R.H.
        • Rotter J.I.
        • et al.
        Neutrophil autoantibodies in ulcerative colitis: Familial aggregation and genetic heterogeneity.
        Gastroenterology. 1992; 103: 456-461
        • Shanahan F.
        • Leman B.
        • Deem R.
        • et al.
        Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease.
        J Clin Immunol. 1989; 9: 55-64
        • Sharon P.
        • Stenson W.F.
        Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.
        Gastroenterology. 1984; 86: 453-460
        • Sharon P.
        • Ligumsky M.
        • Rachmilewitz D.
        • Zor U.
        Role of prostaglandins in ulcerative colitis: Enhanced production during active disease and inhibition by sulfasalazine.
        Gastroenterology. 1978; 75: 638-640
        • Shorter R.G.
        • Cardoza M.
        • Spencer R.J.
        • Huizenga K.A.
        Further studies of in vitro cytotoxicity of lymphocytes from patients with ulcerative and granulomatous colitis for allogeneic colonic epithelial cells including the effects of colectomy.
        Gastroenterology. 1969; 56: 304-314
        • Shorter R.G.
        • McGill D.B.
        • Bahn R.C.
        Cytotoxicity of mononuclear cells for autologous colonic epithelial cells in colonic disease.
        Gastroenterology. 1984; 86: 13-22
        • Smith C.W.
        • Hollers J.C.
        • Patrick R.A.
        • Hassett C.
        Motility and adhesiveness in human neutrophils, effect of chemotactic factors.
        J Clin Invest. 1979; 63: 221-229
        • Smolen J.S.
        • Gangl A.
        • Polterauer P.
        • et al.
        HLA antigens in inflammatory bowel disease.
        . 1982; 82: 34-38
        • Sobajima J.
        • Ozaki S.
        • Okazaki T.
        • et al.
        Antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: Anti-cathepsin G and a novel antibody correlate with a refractory type.
        Clin Exp Immunol. 1996; 105: 120-124
        • Soltis R.D.
        • Hasz D.
        • Morris M.J.
        • Wilson I.D.
        Evidence against the presence of circulating immune complexes in chronic inflammatory bowel disease.
        Gastroenterology. 1976; 76: 1380-1385
        • Stoffel M.P.
        • Csernok E.
        • Herzberg C.
        • et al.
        Antineutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): A new seromarker for inflammatory bowel disease and associated disorders.
        Clin Exp Immunol. 1996; 104: 54-59
        • Sung J.Y.
        • Chan K.L.
        • Hsu R.
        • et al.
        Ulcerative colitis and antineutrophil cytoplasmic antibodies in Hong Kong Chinese.
        Am J Gastroenterol. 1993; 88: 864-869
        • Sung J.Y.
        • Chan F.K.L.
        • Lawton J.
        • et al.
        Anti-neutrophil cytoplasmic antibodies (ANCA) and inflammatory bowel diseases in Chinese.
        Dig Dis Sei. 1994; 39: 886-892
        • Targan S.R.
        • Landers C.
        • Vidrich A.
        • Czaja A.J.
        High-titer antineutrophil cytoplasmic antibodies in type 1 autoimmune hepatitis.
        Gastroenterology. 1995; 108: 1159-1166
        • Targan S.R.
        • Landers C.J.
        • Cobb L.
        • et al.
        Perinuclear antineutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients.
        J Immunol. 1995; 155: 3262-3267
        • Thomas D.W.
        • Sinatra F.R.
        • Merritte R.J.
        Fecal alpha-l-antitrypsin excretion in young people with Crohn's disease.
        J Pediatr Gastroenterol Nutr. 1983; 2: 491-496
        • van der Woude F.J.
        • Rasmussen N.
        • Lobatto S.
        • et al.
        Autoantibodies to neutrophils and monocytes: A new tool for diagnosis and marker of disease activity in Wegener's granulomatosis.
        Lancet. 1985; 2: 425-429
        • van Spreeuel J.P.
        • Lindeman J.
        • Meijer C.J.L.M.
        A quantitative study of immunoglobulin containing cells in the differential diagnosis of acute colitis.
        J Clin Pathol. 1985; 38: 774-777
        • Vecchi M.
        • Gionchetti P.
        • Bianchi M.B.
        • et al.
        p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis.
        Lancet. 1994; 344: 886-887
        • Verspaget H.W.
        • Pena A.S.
        • Weterman I.T.
        • Lamers C.B.H.W.
        Disordered regulation of the in vitro immunoglobulin synthesis by intestinal mononuclear cells in Crohn's disease.
        Gut. 1988; 29: 503-510
        • Verspaget H.W.
        • Pena A.S.
        • Weterman I.T.
        • Lamers C.B.H.W.
        Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.
        Gut. 1988; 29: 223-228
        • Victorino R.M.M.
        • Hodgson H.J.F.
        Spontaneous suppressor cell function in inflammatory bowel disease.
        Dig Dis Sei. 1981; 26: 801-806
        • Vidrich A.
        • Lee J.
        • James E.
        • et al.
        Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: Ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
        J Clin Immunol. 1995; 15: 293-299
        • Wallace J.L.
        • MacNaughton W.K.
        • Morris G.P.
        • Beck P.L.
        Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.
        Gastroenterology. 1989; 96: 29-36
        • Ward M.
        • Eastwood A.S.
        Serum complement components C2 and C4 in inflammatory bowel disease.
        Digestion. 1979; 13: 100-103
        • Yang P.
        • Jarnerot G.
        • Danielsson D.
        • et al.
        P-ANCA in monozygotic twins with inflammatory bowel disease.
        Gut. 1995; 36: 887-890

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30206-3

      Copyright

      © 1997 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX